| Scorecard |
|---|
|
---
|
|
Lipper
---
|
|
Zacks Investment Research
3
(Hold)
|
|
Standard & Poor's
---
|
|
TheStreet.com
---
|
Fund Holdings
Asset Allocation
| % Long | % Net | |
|---|---|---|
| Cash | 58.02 | 58.02 |
| Stocks | 32.54 | 32.54 |
| Bonds | 0.0 | 0.0 |
| Other | 0.01 | 0.01 |
| Foreign Bonds | 0.0 | 0.0 |
| Foreign Stocks | 9.44 | 9.44 |
| Convertible | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 |
Updated 04.30.2013
Top 10 Holdings
Performance as of 05.31.2013
Portfolio as of 04.30.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| Roche Holding AG ADR | RHHBY | 20.36 | 2.88 |
| AbbVie Inc | ABBV | 29.27 | 2.19 |
| Baxter International Inc. | BAX | 6.35 | 1.82 |
| Biomarin Pharmaceutical, Inc. | BMRN | 21.5 | 1.77 |
| ViroPharma, Inc. | VPHM | 22.8 | 1.64 |
| Cardinal Health Inc | CAH | 15.36 | 1.37 |
| Maximus, Inc. | MMS | 18.78 | 1.35 |
| Analogic Corporation | ALOG | 7.82 | 1.28 |
| Sanofi ADR | SNY | 15.08 | 1.23 |
| McKesson, Inc. | MCK | 16.48 | 1.23 |
